Inventor
ROY SAUMYA
IN14 patents
⚠️ This page may combine multiple inventors who share the name “ROY SAUMYA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
13 patentsUS9790169B2Oct 17, 2017
IDO inhibitors
BRISTOL MYERS SQUIBB CO19 citations91
US10959986B2Mar 30, 2021
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO3 citations72
US10399933B2Sep 3, 2019
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
BRISTOL MYERS SQUIBB CO3 citations72
US10399932B2Sep 3, 2019
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
BRISTOL MYERS SQUIBB CO3 citations71
US10167254B2Jan 1, 2019
IDO inhibitors
BRISTOL MYERS SQUIBB CO1 citations71
US10669272B2Jun 2, 2020
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO4 citations70
US12145927B2Nov 19, 2024
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations61
US11253525B2Feb 22, 2022
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations61
US11713316B2Aug 1, 2023
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations59
US10954238B1Mar 23, 2021
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations59
US12059420B2Aug 13, 2024
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO0 citations51
US11964973B2Apr 23, 2024
Substituted bicyclic compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations50
US11584747B2Feb 21, 2023
Substituted pyridopyrimidinonyl compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations48